Clinical and Translational

How to reduce your test turnaround for large panels in molecular oncology

January 02, 2020
Speaker: Sheryl Elkin, CSO, N-of-One.a QIAGEN Company

Interested in learning more?

Click here

Related videos

Clinical and Translational

LeukoVantage: A Quest/Qiagen Partnership Providing Clinical Insights Into Myeloid Malignancies

269 views December 09, 2019

The integration of next-generation sequencing (NGS) into the diagnostic...

Clinical and Translational

Cancer Gene Variant Detection Using a Pre-Optimized Sample to Report Workflow

271 views October 30, 2019

BRCA1/BRCA2 genes represent the best examples for our current understanding...

Clinical and Translational

Increasing the efficiency of diagnostic odysseys

323 views September 16, 2019

Despite rapid cost reductions in sequencing technologies and an...

Clinical and Translational

Managing Multiple Biomarker Therapeutic Development

310 views September 12, 2019

For the past two decades, the paradigm in the field has been “one biomarker,...